Psychosocial cardiovascular risk factors

Authors: Jan Bruthans
Authors‘ workplace: Centrum kardiovaskulární prevence 1. LF UK a Thomayerovy nemonice, Praha
Published in: AtheroRev 2020; 5(2): 107-111


Low socio-ecomic status, in the Czech Republic determined above all by achieved only basic education, lack of social support, stress at work and in family life, hostility, type D („distressed“) personality, depression and anxiety increase the risk of developing cardiovascular (CV) disease and worsen its prognosis. Psychosocial factors act as bariers to health promotion and lifestyle improvement and decrease prevention and treatment adherence. They are associated, especially low socio-economic status, with increased prevalence of classical CV risk factors. The differences in prevalence of cardiovascular risk factors, e.g. according to education, are more pronounced in factors due to unhealthy life style (smoking, obesity, less physical aktivity and less pronounced in „treatable“ factors (high blood pressure, hypercholesterolemia) and increased recently. Searching for and control of classical CV risk factors is in persons with low socio-economic status fundamental and substantially improves their prognosis. Control of psychosocial stress and treatment of depression and anxiety improves quality of life and facilitates behavioural change, the evidence, that they prevent CV disease and improve outcomes is still inconclusive. Nevertheless, in our patients we should search actively for psychosocial risk factors and try to control them, though it involves time, empathy and often team collaboration.


anxiosity – cardiovascular risk – depression – low socio-economic status – psychosocial factors – socio-economic factors

  1. Piepoli MF, Hoes AW, Agewall S et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2016; 37(29): 2315–2381. Dostupné z DOI: <>.
  2. Marmot M, Wilkinson RG. Social determinants of health, the solid facts. 2nd ed. WHO 2003. ISBN 9789289012874. Dostupné z WWW: <>.
  3. OECD. Health at a glance 2017: OECD indicators. OECD: Paris 2017. Dostupné z WWW: <>.
  4. Lustigova M, Dzurova D, Pikhart H et al. Cardiovascular health among the Czech population at the beginning of the 21st century: a 12- year follow-up study. J Epidemiol Community Health 2018; 72(5): 442–448. Dostupné z DOI: <–209967>.
  5. Lunch JW, Kaplan GA, Cohen RD et al. Do cardiovascular risk factors explain the relation between socioeconomic status, risk of all cause mortality, cardiovascular mortality and acute myocardial infarction? Am J Epidemiol 1996; 144(10): 934–942. Dostupné z DOI: <>.
  6. Šimon J, Cajzl L, Křižanovská M et al. Occupation and education in relation to risk factors of ischaemic heart disease in the male industrial population. Cor Vasa 1986; 28(3): 167–176.
  7. Zemřelí 2017. ÚZIS ČR 2018. Dostupné z WWW: <>.
  8. Spáčil J. Sociální, ekonomické a psychické vlivy jako rizikové faktory kardiovaskulárních chorob. Vnitř Lék 2009; 55(11): 1030–1034.
  9. Bruthans J, Dzúrová D, Holub J, et al. Recentní vývoj kardiovaskulární morbidity a mortality a některých faktorů ji ovlivňujících. Výroční sjezd ČKS Brno 2000 (ústní sdělení).
  10. Alter DA, Franklin B, Ko DT et al. Socioeconomic status, functional recovery, and long-term mortality among patients surviving acute myocardial infarction. PLoS One 2014; 8(6): e65130. Dostupné z DOI: <>.
  11. Rosolová H, Šimon J, Šefrna F. Impact of cardiovascular risk factors on morbidity and mortality in the Czech middle aged men: Pilsen longitudinal study. Cardiology 1994; 85(1): 61–68.
  12. Albert MA, Glynn RJ, Buring J et al. Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events. Circulation 2006; 114(24): 2619–2626. Dostupné z DOI: <>.
  13. Bruthans J. Kardiovaskulární onemocnění v České republice v letech 1965–2014 a faktory, které je ovlivňovaly. Galén: Praha 2017. ISBN 978–8087079–54–6.
  14. Peasey A, Bobak M, Kubinova R et al. Determinants of cardiovascular disease and other non-communicable diseases in Central and Eastern Europe: rationale and design of the HAPIEE Study. BMC Public Health 2006; 6: 255. Dostupné z DOI: <–2458–6-255>.
  15. Bacquer DD, Backer DD, Bruthans J et al. Socio-economic characteristics of patients with coronary heart disease in relation to their cardiovascular risk profile. Eur J Prev Cardiology 2020; 27. Podáno k publikování.
  16. Bruthans J, Šulc P, Wohlfahrt P et al. Mění se vztah mezi vzděláním a prevalencí a kontrolou kardiovaskulárních rizikových faktorů? Ústní sdělení. XXXVI. konference České společnosti pro hypertenzi, XXVIII. Konference pracovní skupiny Preventivní kardiologie ČKS, blok České asociace srdečního selhání, Mikulov, 4. 10. 2019.
  17. Pogosova N, Kotseva K, Bacquer DD et al. Psychosocial risk factors in relation to other cardiovascular risk factors in coronary heart disease: Results from the EUROASPIRE IV survey. Eur J Prev Cardiol 2017; 24(13): 1371–1380. Dostupné z DOI: <>.
  18. Kozela M, Bobak M, Besala A et al. The association of depressive symptoms with cardiovascular and all-cause mortality in Central and Eastern Europe: prospective results of the HAPIEE Study. Eur J Prev Cardiol 2016; 23(17): 1839–1847. Dostupné z DOI: <>.
  19. Szpakowski N, Bennel MC, Qiu F et al. Clinical impact of subsequent depression in patients with a new diagnosis of stable angina: a population based study. Circ Cardiovasc Qual Outcomes 2016; 9(6): 731–739. Dostupné z DOI: <>.
  20. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67(6): 361–370.
  21. Ware JE jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). Conceptual Framework and item selection. Med Care 1992; 30(6): 473–483.
  22. Mayer O Jr, Bruthans J, Seidlerová J et al. Mood disorders impaired quality of life but not the mortality or morbidity risk in stable coronary heart disease patients. Acta Cardiologica 2019. Dostupné z DOI: <>.
  23. Jokinen J, Nordstrom P. HPA hyperactivity and cardiovascular mortality in mood disorder inpatients. J Affect Disord 2009; 116(1–2): 88–92. Dostupné z DOI: <>.
  24. Aydin Sunbul E, Sunbul M, Gulec H. The impact of major depression on heart rate variability and endothelial dysfunction in patients with stable coronary artery disease. Gen Hosp Psychiatry 2017; 44: 4–9. Dostupné z DOI: <>.
  25. Thombs BD, de Jonge P, Coyne JC et al. Depression screening and patient outcomes in cardiovascular care: a systematic review. JAMA 2008; 300(18): 2161–2171. Dostupné z DOI: <>.
  26. Glassman AH, O´Connor CM, Califf RM et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002; 288(6): 701–709. Dostupné z DOI: <>.
Angiology Diabetology Internal medicine Cardiology General practitioner for adults

Article was published in

Athero Review

Issue 2

2020 Issue 2

Most read in this issue
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.


Don‘t have an account?  Create new account